“This isn’t about opposing legitimate business success. It’s about asking whether companies that chose the state marijuana pathway should receive federal advantages while MMJ companies spent years and millions of dollars complying with the FDA and DEA pathway are still waiting for equal treatment under the law.”- Duane Boise, CEO MMJ International Holdings.



